Titelia

Holdings of Decheng Capital LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
11 in 1 countries
Top ten
99.9 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1CG oncology Inc 6,371,669431.2M $
2Nuvation Bio Inc 25,954,439111.3M $
3Upstream Bio Inc 2,724,86824.5M $
4Aclaris Therapeutics Inc 4,041,73615.2M $
5Aardvark Therapeutics Inc 3,917,29914.8M $
6Arcus Biosciences Inc 477,81910.3M $
7Revolution Medicines Inc 93,5009.1M $
8Equillium Inc 4,447,3088.9M $
9Zentalis Pharmaceuticals Inc 1,323,3273.1M $
10Krystal Biotech Inc 7,3001.9M $
11Pyxis Oncology Inc 326,810477.1K $

Download this table: CSV, JSON

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 100.0 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States11630.8M $100.00 %
Cite this page

Titelia. "Holdings of Decheng Capital LLC". https://titelia.com/en/funds/US13F2010850